Ten-year trends in lipid management among patients after myocardial infarction in South Korea

Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean patients with acute myocardial infarction are limited. This study aimed to determine the 10-year temporal trends in dyslipidemia prevalence and...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 19; no. 10; p. e0304710
Main Authors Oh, Seok, Cho, Kyung Hoon, Kim, Min Chul, Sim, Doo Sun, Hong, Young Joon, Kim, Ju Han, Ahn, Youngkeun, Lee, Sang Yeub, Shin, Min-Ho, Kim, Weon, Jeong, Myung Ho
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 03.10.2024
Public Library of Science (PLoS)
Subjects
Online AccessGet full text
ISSN1932-6203
1932-6203
DOI10.1371/journal.pone.0304710

Cover

Abstract Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean patients with acute myocardial infarction are limited. This study aimed to determine the 10-year temporal trends in dyslipidemia prevalence and lipid management in this patient population. The study used a merged database of two nationwide observational cohorts (2011-2020) that included 26,751 participants. The primary endpoints were the achievement rates of the (1) absolute low-density lipoprotein cholesterol (LDL-C) target of <70 mg/dL (<1.8 mmol/L), (2) relative LDL-C target reduction of >50% from the baseline, (3) absolute or relative LDL-C target (American target), and (4) both absolute and relative LDL-C targets (European target). The dyslipidemia prevalence increased from 11.1% to 17.1%, whereas the statin prescription rate increased from 92.9% to 97.0% from 2011 to 2020. The rate of high-intensity statin use increased from 12.80% in 2012 to 69.30% in 2020. The rate of ezetimibe use increased from 4.50% in 2016 to 22.50% in 2020. The high-intensity statin and ezetimibe prescription rates (0.20% to 9.30% from 2016 to 2020) increased gradually. The absolute and relative LDL-C target achievement rates increased from 41.4% and 20.8% in 2012 to 62.5% and 39.5% in 2019, respectively. The American (45.7% in 2012 to 68.6% in 2019) and European (16.5% in 2012 to 33.8% in 2019) target achievement rates also increased. The adoption of lipid management guidelines in clinical practice has improved. However, continued efforts are needed to reduce the risk of recurrent ischemic events.
AbstractList Background Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean patients with acute myocardial infarction are limited. This study aimed to determine the 10-year temporal trends in dyslipidemia prevalence and lipid management in this patient population. Methods and findings The study used a merged database of two nationwide observational cohorts (2011-2020) that included 26,751 participants. The primary endpoints were the achievement rates of the (1) absolute low-density lipoprotein cholesterol (LDL-C) target of <70 mg/dL (50% from the baseline, (3) absolute or relative LDL-C target (American target), and (4) both absolute and relative LDL-C targets (European target). The dyslipidemia prevalence increased from 11.1% to 17.1%, whereas the statin prescription rate increased from 92.9% to 97.0% from 2011 to 2020. The rate of high-intensity statin use increased from 12.80% in 2012 to 69.30% in 2020. The rate of ezetimibe use increased from 4.50% in 2016 to 22.50% in 2020. The high-intensity statin and ezetimibe prescription rates (0.20% to 9.30% from 2016 to 2020) increased gradually. The absolute and relative LDL-C target achievement rates increased from 41.4% and 20.8% in 2012 to 62.5% and 39.5% in 2019, respectively. The American (45.7% in 2012 to 68.6% in 2019) and European (16.5% in 2012 to 33.8% in 2019) target achievement rates also increased. Conclusions The adoption of lipid management guidelines in clinical practice has improved. However, continued efforts are needed to reduce the risk of recurrent ischemic events.
BackgroundDyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean patients with acute myocardial infarction are limited. This study aimed to determine the 10-year temporal trends in dyslipidemia prevalence and lipid management in this patient population.Methods and findingsThe study used a merged database of two nationwide observational cohorts (2011–2020) that included 26,751 participants. The primary endpoints were the achievement rates of the (1) absolute low-density lipoprotein cholesterol (LDL-C) target of <70 mg/dL (<1.8 mmol/L), (2) relative LDL-C target reduction of >50% from the baseline, (3) absolute or relative LDL-C target (American target), and (4) both absolute and relative LDL-C targets (European target).The dyslipidemia prevalence increased from 11.1% to 17.1%, whereas the statin prescription rate increased from 92.9% to 97.0% from 2011 to 2020. The rate of high-intensity statin use increased from 12.80% in 2012 to 69.30% in 2020. The rate of ezetimibe use increased from 4.50% in 2016 to 22.50% in 2020. The high-intensity statin and ezetimibe prescription rates (0.20% to 9.30% from 2016 to 2020) increased gradually. The absolute and relative LDL-C target achievement rates increased from 41.4% and 20.8% in 2012 to 62.5% and 39.5% in 2019, respectively. The American (45.7% in 2012 to 68.6% in 2019) and European (16.5% in 2012 to 33.8% in 2019) target achievement rates also increased.ConclusionsThe adoption of lipid management guidelines in clinical practice has improved. However, continued efforts are needed to reduce the risk of recurrent ischemic events.
Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean patients with acute myocardial infarction are limited. This study aimed to determine the 10-year temporal trends in dyslipidemia prevalence and lipid management in this patient population. The study used a merged database of two nationwide observational cohorts (2011-2020) that included 26,751 participants. The primary endpoints were the achievement rates of the (1) absolute low-density lipoprotein cholesterol (LDL-C) target of <70 mg/dL (50% from the baseline, (3) absolute or relative LDL-C target (American target), and (4) both absolute and relative LDL-C targets (European target). The adoption of lipid management guidelines in clinical practice has improved. However, continued efforts are needed to reduce the risk of recurrent ischemic events.
Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean patients with acute myocardial infarction are limited. This study aimed to determine the 10-year temporal trends in dyslipidemia prevalence and lipid management in this patient population.BACKGROUNDDyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean patients with acute myocardial infarction are limited. This study aimed to determine the 10-year temporal trends in dyslipidemia prevalence and lipid management in this patient population.The study used a merged database of two nationwide observational cohorts (2011-2020) that included 26,751 participants. The primary endpoints were the achievement rates of the (1) absolute low-density lipoprotein cholesterol (LDL-C) target of <70 mg/dL (<1.8 mmol/L), (2) relative LDL-C target reduction of >50% from the baseline, (3) absolute or relative LDL-C target (American target), and (4) both absolute and relative LDL-C targets (European target). The dyslipidemia prevalence increased from 11.1% to 17.1%, whereas the statin prescription rate increased from 92.9% to 97.0% from 2011 to 2020. The rate of high-intensity statin use increased from 12.80% in 2012 to 69.30% in 2020. The rate of ezetimibe use increased from 4.50% in 2016 to 22.50% in 2020. The high-intensity statin and ezetimibe prescription rates (0.20% to 9.30% from 2016 to 2020) increased gradually. The absolute and relative LDL-C target achievement rates increased from 41.4% and 20.8% in 2012 to 62.5% and 39.5% in 2019, respectively. The American (45.7% in 2012 to 68.6% in 2019) and European (16.5% in 2012 to 33.8% in 2019) target achievement rates also increased.METHODS AND FINDINGSThe study used a merged database of two nationwide observational cohorts (2011-2020) that included 26,751 participants. The primary endpoints were the achievement rates of the (1) absolute low-density lipoprotein cholesterol (LDL-C) target of <70 mg/dL (<1.8 mmol/L), (2) relative LDL-C target reduction of >50% from the baseline, (3) absolute or relative LDL-C target (American target), and (4) both absolute and relative LDL-C targets (European target). The dyslipidemia prevalence increased from 11.1% to 17.1%, whereas the statin prescription rate increased from 92.9% to 97.0% from 2011 to 2020. The rate of high-intensity statin use increased from 12.80% in 2012 to 69.30% in 2020. The rate of ezetimibe use increased from 4.50% in 2016 to 22.50% in 2020. The high-intensity statin and ezetimibe prescription rates (0.20% to 9.30% from 2016 to 2020) increased gradually. The absolute and relative LDL-C target achievement rates increased from 41.4% and 20.8% in 2012 to 62.5% and 39.5% in 2019, respectively. The American (45.7% in 2012 to 68.6% in 2019) and European (16.5% in 2012 to 33.8% in 2019) target achievement rates also increased.The adoption of lipid management guidelines in clinical practice has improved. However, continued efforts are needed to reduce the risk of recurrent ischemic events.CONCLUSIONSThe adoption of lipid management guidelines in clinical practice has improved. However, continued efforts are needed to reduce the risk of recurrent ischemic events.
Background Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean patients with acute myocardial infarction are limited. This study aimed to determine the 10-year temporal trends in dyslipidemia prevalence and lipid management in this patient population. Methods and findings The study used a merged database of two nationwide observational cohorts (2011–2020) that included 26,751 participants. The primary endpoints were the achievement rates of the (1) absolute low-density lipoprotein cholesterol (LDL-C) target of <70 mg/dL (<1.8 mmol/L), (2) relative LDL-C target reduction of >50% from the baseline, (3) absolute or relative LDL-C target (American target), and (4) both absolute and relative LDL-C targets (European target). The dyslipidemia prevalence increased from 11.1% to 17.1%, whereas the statin prescription rate increased from 92.9% to 97.0% from 2011 to 2020. The rate of high-intensity statin use increased from 12.80% in 2012 to 69.30% in 2020. The rate of ezetimibe use increased from 4.50% in 2016 to 22.50% in 2020. The high-intensity statin and ezetimibe prescription rates (0.20% to 9.30% from 2016 to 2020) increased gradually. The absolute and relative LDL-C target achievement rates increased from 41.4% and 20.8% in 2012 to 62.5% and 39.5% in 2019, respectively. The American (45.7% in 2012 to 68.6% in 2019) and European (16.5% in 2012 to 33.8% in 2019) target achievement rates also increased. Conclusions The adoption of lipid management guidelines in clinical practice has improved. However, continued efforts are needed to reduce the risk of recurrent ischemic events.
Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean patients with acute myocardial infarction are limited. This study aimed to determine the 10-year temporal trends in dyslipidemia prevalence and lipid management in this patient population. The study used a merged database of two nationwide observational cohorts (2011-2020) that included 26,751 participants. The primary endpoints were the achievement rates of the (1) absolute low-density lipoprotein cholesterol (LDL-C) target of <70 mg/dL (<1.8 mmol/L), (2) relative LDL-C target reduction of >50% from the baseline, (3) absolute or relative LDL-C target (American target), and (4) both absolute and relative LDL-C targets (European target). The dyslipidemia prevalence increased from 11.1% to 17.1%, whereas the statin prescription rate increased from 92.9% to 97.0% from 2011 to 2020. The rate of high-intensity statin use increased from 12.80% in 2012 to 69.30% in 2020. The rate of ezetimibe use increased from 4.50% in 2016 to 22.50% in 2020. The high-intensity statin and ezetimibe prescription rates (0.20% to 9.30% from 2016 to 2020) increased gradually. The absolute and relative LDL-C target achievement rates increased from 41.4% and 20.8% in 2012 to 62.5% and 39.5% in 2019, respectively. The American (45.7% in 2012 to 68.6% in 2019) and European (16.5% in 2012 to 33.8% in 2019) target achievement rates also increased. The adoption of lipid management guidelines in clinical practice has improved. However, continued efforts are needed to reduce the risk of recurrent ischemic events.
Audience Academic
Author Kim, Weon
Hong, Young Joon
Shin, Min-Ho
Jeong, Myung Ho
Kim, Min Chul
Sim, Doo Sun
Cho, Kyung Hoon
Ahn, Youngkeun
Kim, Ju Han
Lee, Sang Yeub
Oh, Seok
AuthorAffiliation 6 Department of Cardiology, Gwangju Veterans Hospital, Gwangju, Republic of Korea
1 Department of Cardiology, Chonnam National University Hospital, Gwangju, Republic of Korea
3 Chung-Ang University Gwangmyeong Hospital and Department of Internal Medicine, Division of Cardiology, Chung-Ang University College of Medicine, Gwangmyeong, Republic of Korea
5 Department of Internal Medicine, Division of Cardiology, Kyung Hee University Hospital, Kyung Hee University, Seoul, Republic of Korea
2 Department of Cardiology, Chonnam National University Medical School, Gwangju, Republic of Korea
4 Department of Preventive Medicine, Chonnam National University Medical School, Hwasun, Republic of Korea
Baylor Scott and White, Texas A&M College of Medicine, UNITED STATES
AuthorAffiliation_xml – name: Baylor Scott and White, Texas A&M College of Medicine, UNITED STATES
– name: 5 Department of Internal Medicine, Division of Cardiology, Kyung Hee University Hospital, Kyung Hee University, Seoul, Republic of Korea
– name: 3 Chung-Ang University Gwangmyeong Hospital and Department of Internal Medicine, Division of Cardiology, Chung-Ang University College of Medicine, Gwangmyeong, Republic of Korea
– name: 1 Department of Cardiology, Chonnam National University Hospital, Gwangju, Republic of Korea
– name: 4 Department of Preventive Medicine, Chonnam National University Medical School, Hwasun, Republic of Korea
– name: 2 Department of Cardiology, Chonnam National University Medical School, Gwangju, Republic of Korea
– name: 6 Department of Cardiology, Gwangju Veterans Hospital, Gwangju, Republic of Korea
Author_xml – sequence: 1
  givenname: Seok
  orcidid: 0000-0002-6193-2982
  surname: Oh
  fullname: Oh, Seok
– sequence: 2
  givenname: Kyung Hoon
  orcidid: 0000-0002-0377-6352
  surname: Cho
  fullname: Cho, Kyung Hoon
– sequence: 3
  givenname: Min Chul
  surname: Kim
  fullname: Kim, Min Chul
– sequence: 4
  givenname: Doo Sun
  surname: Sim
  fullname: Sim, Doo Sun
– sequence: 5
  givenname: Young Joon
  surname: Hong
  fullname: Hong, Young Joon
– sequence: 6
  givenname: Ju Han
  orcidid: 0000-0002-3186-0770
  surname: Kim
  fullname: Kim, Ju Han
– sequence: 7
  givenname: Youngkeun
  surname: Ahn
  fullname: Ahn, Youngkeun
– sequence: 8
  givenname: Sang Yeub
  surname: Lee
  fullname: Lee, Sang Yeub
– sequence: 9
  givenname: Min-Ho
  surname: Shin
  fullname: Shin, Min-Ho
– sequence: 10
  givenname: Weon
  orcidid: 0000-0003-1264-9870
  surname: Kim
  fullname: Kim, Weon
– sequence: 11
  givenname: Myung Ho
  surname: Jeong
  fullname: Jeong, Myung Ho
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39361921$$D View this record in MEDLINE/PubMed
BookMark eNqNk1uL1DAUx4usuBf9BqIFQfRhxtx6yZMsi5fBhQV39U3CaZp0srTJmKTifHszTneZyj5IH9qc_M4_Pf-cc5odWWdVlj3HaIlphd_dutFb6JebFF4iiliF0aPsBHNKFiVB9Ojg-zg7DeEWoYLWZfkkO6aclpgTfJL9uFF2sVXg8-iVbUNubN6bjWnzASx0alA25jA42-UbiCatQg46Kp8PWyfBtwb6lKPBy2ic3aVfuzGu8y_OK3iaPdbQB_Vsep9l3z5-uLn4vLi8-rS6OL9cyJKRuGg0A05bVmOQpEW8xTVBmFdcStCUMV6AbhBo1eK2LihuCNKgcaN0XUiJJD3LXu51N70LYnImCIoxqTjFpEjEak-0Dm7FxpsB_FY4MOJvwPlOgI9G9kog3MhKpyzOEZOMAiMNKokuGp1s4yRpvZ9OG5tBtTKZ4qGfic53rFmLzv0SGKdaWM2TwptJwbufowpRDCZI1fdglRv3P14XVVXihL76B324vInqIFWQ7sOlg-VOVJzXGKOSlRQlavkAlZ5WDUamPtImxWcJb2cJiYnqd-xgDEGsrr_-P3v1fc6-PmDXCvq4Dq4fdy0U5uCLQ6vvPb5r4ASwPSC9C8ErfY9gJHZzcmeX2M2JmOaE_gHd_APx
Cites_doi 10.1038/s41569-021-00541-4
10.1001/jama.290.16.2174
10.1136/bmj.316.7134.838
10.1001/jamacardio.2019.0911
10.1186/s12944-019-1080-x
10.1161/CIRCOUTCOMES.121.008861
10.1056/NEJMoa040583
10.1016/j.jcin.2012.05.009
10.1186/s12944-019-1158-5
10.1093/eurheartj/ehw272
10.1016/S0140-6736(18)32225-6
10.1177/0020715206070267
10.1097/MED.0b013e3283444b09
10.1093/eurheartj/ehz455
10.1177/1741826711422764
10.4070/kcj.2020.0196
10.3390/jcm12093187
10.3349/ymj.2021.62.5.400
10.1177/2040622316672544
10.12997/jla.2023.12.1.12
10.12997/jla.2021.10.2.202
10.1016/j.jacc.2022.07.006
10.3346/jkms.2021.36.e259
10.1016/j.jacl.2023.09.013
10.1016/j.amjcard.2005.03.069
10.1253/circj.CJ-16-0061
10.1016/j.jacl.2022.05.002
10.1056/NEJMoa1410489
10.3390/jcm11061593
10.1371/journal.pone.0152207
10.3904/kjim.2021.204
10.1016/j.jacc.2018.11.003
10.1016/j.jacc.2013.11.002
10.3904/kjim.2018.312
10.1016/j.cpcardiol.2021.101068
10.1161/01.CIR.0000027560.41358.B3
10.1001/jamacardio.2016.4052
10.3346/jkms.2023.38.e419
10.3904/kjim.2018.381
10.3389/fcvm.2021.789931
10.1016/j.jacc.2020.03.033
10.12997/jla.2019.8.2.204
10.1186/s12872-023-03231-w
ContentType Journal Article
Copyright Copyright: © 2024 Oh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
COPYRIGHT 2024 Public Library of Science
2024 Oh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2024 Oh et al 2024 Oh et al
2024 Oh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: Copyright: © 2024 Oh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
– notice: COPYRIGHT 2024 Public Library of Science
– notice: 2024 Oh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2024 Oh et al 2024 Oh et al
– notice: 2024 Oh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0304710
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
ProQuest Nursing and Allied Health Journals - PSU access expires 11/30/25.
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Materials Science Collection
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agricultural Science Database
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
ProQuest advanced technologies & aerospace journals
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Agricultural Science Database

MEDLINE - Academic





MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
DocumentTitleAlternate Trends in lipid management after AMI in South Korea
EISSN 1932-6203
ExternalDocumentID 3112793125
oai_doaj_org_article_01bc7f3129904c43a42b062f5bf93692
PMC11449489
A811064630
39361921
10_1371_journal_pone_0304710
Genre Journal Article
Observational Study
GeographicLocations Republic of Korea
South Korea
United States--US
GeographicLocations_xml – name: Republic of Korea
– name: South Korea
– name: United States--US
GrantInformation_xml – fundername: ;
  grantid: HC21C0077
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
ADRAZ
BBORY
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
RIG
PMFND
3V.
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
7X8
ESTFP
PUEGO
5PM
ID FETCH-LOGICAL-c642t-bf4a93d481ac2d09d18201979ccaf34495afb0afed1d8531b20faf1bef85cc0c3
IEDL.DBID M48
ISSN 1932-6203
IngestDate Sat Jan 04 00:50:55 EST 2025
Wed Aug 27 01:25:10 EDT 2025
Thu Aug 21 18:35:02 EDT 2025
Mon Sep 08 14:31:54 EDT 2025
Fri Jul 25 10:18:31 EDT 2025
Tue Jun 17 22:03:56 EDT 2025
Tue Jun 10 21:02:57 EDT 2025
Fri Jun 27 05:27:31 EDT 2025
Fri Jun 27 05:27:55 EDT 2025
Thu May 22 21:27:29 EDT 2025
Thu Apr 03 07:06:31 EDT 2025
Tue Jul 01 03:45:29 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License Copyright: © 2024 Oh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c642t-bf4a93d481ac2d09d18201979ccaf34495afb0afed1d8531b20faf1bef85cc0c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
Competing Interests: The authors have declared that no competing interests exist.
ORCID 0000-0002-0377-6352
0000-0002-6193-2982
0000-0003-1264-9870
0000-0002-3186-0770
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0304710
PMID 39361921
PQID 3112793125
PQPubID 1436336
PageCount e0304710
ParticipantIDs plos_journals_3112793125
doaj_primary_oai_doaj_org_article_01bc7f3129904c43a42b062f5bf93692
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11449489
proquest_miscellaneous_3112857761
proquest_journals_3112793125
gale_infotracmisc_A811064630
gale_infotracacademiconefile_A811064630
gale_incontextgauss_ISR_A811064630
gale_incontextgauss_IOV_A811064630
gale_healthsolutions_A811064630
pubmed_primary_39361921
crossref_primary_10_1371_journal_pone_0304710
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-10-03
PublicationDateYYYYMMDD 2024-10-03
PublicationDate_xml – month: 10
  year: 2024
  text: 2024-10-03
  day: 03
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2024
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References SM Grundy (pone.0304710.ref009) 2019; 4
C Bähler (pone.0304710.ref019) 2012; 19
AL Catapano (pone.0304710.ref016) 2016; 37
SY Lee (pone.0304710.ref043) 2023; 38
F Mach (pone.0304710.ref010) 2020; 41
CP Cannon (pone.0304710.ref013) 2020; 75
NJ Stone (pone.0304710.ref030) 2014; 63
A Pirillo (pone.0304710.ref006) 2021; 18
SY Choi (pone.0304710.ref012) 2020; 35
Y Kim (pone.0304710.ref014) 2019; 34
A Halkin (pone.0304710.ref023) 2005; 96
SM Grundy (pone.0304710.ref008) 2019; 139
SMJ Cho (pone.0304710.ref007) 2021; 10
X Su (pone.0304710.ref011) 2019; 18
S Talic (pone.0304710.ref037) 2022; 47
S Oh (pone.0304710.ref026) 2022; 11
F Rodriguez (pone.0304710.ref028) 2017; 2
JH Kim (pone.0304710.ref015) 2016; 80
UN Khot (pone.0304710.ref024) 2003; 290
CP Cannon (pone.0304710.ref027) 2004; 350
V Barrios (pone.0304710.ref040) 2023; 12
RH Mehta (pone.0304710.ref005) 1998; 316
HK Kim (pone.0304710.ref025) 2020; 50
SM Grundy (pone.0304710.ref029) 2019; 73
CP Cannon (pone.0304710.ref035) 2015; 372
C Marquina (pone.0304710.ref038) 2022; 16
N Salari (pone.0304710.ref003) 2023; 23
KH Cho (pone.0304710.ref001) 2021; 36
DM Lloyd-Jones (pone.0304710.ref017) 2022; 80
X Han (pone.0304710.ref021) 2021; 62
G. Boden (pone.0304710.ref020) 2011; 18
S Oh (pone.0304710.ref004) 2022; 37
AR Zheutlin (pone.0304710.ref042) 2022; 15
C Bardolia (pone.0304710.ref033) 2021; 8
YS Yang (pone.0304710.ref036) 2023; 12
JD Stanaway (pone.0304710.ref002) 2018; 392
FC Pampel (pone.0304710.ref018) 2006; 47
KH Han (pone.0304710.ref031) 2019; 8
T Nakano (pone.0304710.ref034) 2016; 11
M Kayıkcioglu (pone.0304710.ref041) 2023; 17
KY Chen (pone.0304710.ref044) 2012; 5
J Al Suwaidi (pone.0304710.ref022) 2002; 106
D Hammersley (pone.0304710.ref032) 2017; 8
YS Yang (pone.0304710.ref039) 2020; 19
References_xml – volume: 18
  start-page: 689
  year: 2021
  ident: pone.0304710.ref006
  article-title: Global epidemiology of dyslipidaemias.
  publication-title: Nat Rev Cardiol
  doi: 10.1038/s41569-021-00541-4
– volume: 290
  start-page: 2174
  year: 2003
  ident: pone.0304710.ref024
  article-title: Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification
  publication-title: JAMA
  doi: 10.1001/jama.290.16.2174
– volume: 316
  start-page: 838
  year: 1998
  ident: pone.0304710.ref005
  article-title: Secondary prevention in acute myocardial infarction
  publication-title: BMJ
  doi: 10.1136/bmj.316.7134.838
– volume: 4
  start-page: 589
  year: 2019
  ident: pone.0304710.ref009
  article-title: 2018 American Heart Association/American College of Cardiology/Multisociety guideline on the management of blood cholesterol-secondary prevention
  publication-title: JAMA Cardiol
  doi: 10.1001/jamacardio.2019.0911
– volume: 18
  start-page: 134
  year: 2019
  ident: pone.0304710.ref011
  article-title: Evidence for changing lipid management strategy to focus on non-high density lipoprotein cholesterol
  publication-title: Lipids Health Dis
  doi: 10.1186/s12944-019-1080-x
– volume: 15
  start-page: e008861
  year: 2022
  ident: pone.0304710.ref042
  article-title: Lipid-lowering therapy use and intensification among United States veterans following myocardial infarction or coronary revascularization between 2015 and 2019.
  publication-title: Circ Cardiovasc Qual Outcomes
  doi: 10.1161/CIRCOUTCOMES.121.008861
– volume: 350
  start-page: 1495
  year: 2004
  ident: pone.0304710.ref027
  article-title: Intensive versus moderate lipid lowering with statins after acute coronary syndromes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa040583
– volume: 5
  start-page: 936
  year: 2012
  ident: pone.0304710.ref044
  article-title: Unrestricted use of 2 new-generation drug-eluting stents in patients with acute myocardial infarction: a propensity score-matched analysis.
  publication-title: JACC Cardiovasc Interv.
  doi: 10.1016/j.jcin.2012.05.009
– volume: 19
  start-page: 5
  year: 2020
  ident: pone.0304710.ref039
  article-title: Low-density lipoprotein cholesterol goal attainment rates in high-risk patients with cardiovascular diseases and diabetes mellitus in Korea: a retrospective cohort study
  publication-title: Lipids Health Dis
  doi: 10.1186/s12944-019-1158-5
– volume: 37
  start-page: 2999
  year: 2016
  ident: pone.0304710.ref016
  article-title: 2016 ESC/EAS guidelines for the management of dyslipidaemias
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehw272
– volume: 392
  start-page: 1923
  year: 2018
  ident: pone.0304710.ref002
  article-title: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  publication-title: Lancet
  doi: 10.1016/S0140-6736(18)32225-6
– volume: 47
  start-page: 466
  year: 2006
  ident: pone.0304710.ref018
  article-title: Global patterns and determinants of sex differences in smoking.
  publication-title: Int J Comp Sociol
  doi: 10.1177/0020715206070267
– volume: 18
  start-page: 139
  year: 2011
  ident: pone.0304710.ref020
  article-title: Obesity, insulin resistance and free fatty acids
  publication-title: Curr Opin Endocrinol Diabetes Obes
  doi: 10.1097/MED.0b013e3283444b09
– volume: 41
  start-page: 111
  year: 2020
  ident: pone.0304710.ref010
  article-title: 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehz455
– volume: 19
  start-page: 1184
  year: 2012
  ident: pone.0304710.ref019
  article-title: Lower age at first myocardial infarction in female compared to male smokers.
  publication-title: Eur J Prev Cardiol
  doi: 10.1177/1741826711422764
– volume: 50
  start-page: 845
  year: 2020
  ident: pone.0304710.ref025
  article-title: 2020 Korean Society of Myocardial Infarction expert consensus document on pharmacotherapy for acute myocardial infarction
  publication-title: Korean Circ J
  doi: 10.4070/kcj.2020.0196
– volume: 12
  start-page: 3187
  year: 2023
  ident: pone.0304710.ref040
  article-title: Real-world attainment of low-density lipoprotein cholesterol goals in patients at high risk of cardiovascular disease treated with high-intensity statins: the TERESA study.
  publication-title: J Clin Med
  doi: 10.3390/jcm12093187
– volume: 62
  start-page: 400
  year: 2021
  ident: pone.0304710.ref021
  article-title: Higher long-term mortality in patients with non-ST-elevation myocardial infarction than ST-elevation myocardial infarction after discharge.
  publication-title: Yonsei Med J
  doi: 10.3349/ymj.2021.62.5.400
– volume: 8
  start-page: 4
  year: 2017
  ident: pone.0304710.ref032
  article-title: Ezetimibe: an update on its clinical usefulness in specific patient groups.
  publication-title: Ther Adv Chronic Dis
  doi: 10.1177/2040622316672544
– volume: 12
  start-page: 12
  year: 2023
  ident: pone.0304710.ref036
  article-title: Lipid Management in Korean people with type 2 diabetes mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis consensus statement
  publication-title: J Lipid Atheroscler
  doi: 10.12997/jla.2023.12.1.12
– volume: 10
  start-page: 202
  year: 2021
  ident: pone.0304710.ref007
  article-title: Dyslipidemia Fact Sheets in Korea 2020: an analysis of nationwide population-based data.
  publication-title: J Lipid Atheroscler.
  doi: 10.12997/jla.2021.10.2.202
– volume: 80
  start-page: 1366
  year: 2022
  ident: pone.0304710.ref017
  article-title: 2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Solution Set Oversight Committee
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2022.07.006
– volume: 36
  start-page: e259
  year: 2021
  ident: pone.0304710.ref001
  article-title: Preclinical evaluation of a novel polymer-free everolimus-eluting stent in a mid-term porcine coronary restenosis model.
  publication-title: J Korean Med Sci
  doi: 10.3346/jkms.2021.36.e259
– volume: 139
  start-page: e1082
  year: 2019
  ident: pone.0304710.ref008
  article-title: 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
  publication-title: Circulation
– volume: 17
  start-page: 732
  year: 2023
  ident: pone.0304710.ref041
  article-title: Misperceptions and management of LDL-cholesterol in secondary prevention of patients with familial hypercholesterolemia in cardiology practice: Real-life evidence from the EPHESUS registry.
  publication-title: J Clin Lipidol
  doi: 10.1016/j.jacl.2023.09.013
– volume: 96
  start-page: 325
  year: 2005
  ident: pone.0304710.ref023
  article-title: Impact and determinants of left ventricular function in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction.
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2005.03.069
– volume: 80
  start-page: 1427
  year: 2016
  ident: pone.0304710.ref015
  article-title: Multicenter cohort study of acute myocardial infarction in Korea–Interim analysis of the Korea Acute Myocardial Infarction Registry-National Institutes of Health Registry–.
  publication-title: Circ J
  doi: 10.1253/circj.CJ-16-0061
– volume: 16
  start-page: 498
  year: 2022
  ident: pone.0304710.ref038
  article-title: Attainment of low-density lipoprotein cholesterol goals in patients treated with combination therapy: A retrospective cohort study in primary care.
  publication-title: J Clin Lipidol.
  doi: 10.1016/j.jacl.2022.05.002
– volume: 372
  start-page: 2387
  year: 2015
  ident: pone.0304710.ref035
  article-title: Ezetimibe added to statin therapy after acute coronary syndromes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1410489
– volume: 11
  start-page: 1593
  year: 2022
  ident: pone.0304710.ref026
  article-title: Outcomes of nonagenarians with acute myocardial infarction with or without coronary intervention.
  publication-title: J Clin Med
  doi: 10.3390/jcm11061593
– volume: 11
  start-page: e0152207
  year: 2016
  ident: pone.0304710.ref034
  article-title: Ezetimibe promotes brush border membrane-to-lumen cholesterol efflux in the small intestine.
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0152207
– volume: 37
  start-page: 605
  year: 2022
  ident: pone.0304710.ref004
  article-title: Long-term outcomes in ST-elevation myocardial infarction patients treated according to hospital visit time
  publication-title: Korean J Intern Med
  doi: 10.3904/kjim.2021.204
– volume: 73
  start-page: e285
  year: 2019
  ident: pone.0304710.ref029
  article-title: 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2018.11.003
– volume: 63
  start-page: 2889
  year: 2014
  ident: pone.0304710.ref030
  article-title: 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2013.11.002
– volume: 35
  start-page: 593
  year: 2020
  ident: pone.0304710.ref012
  article-title: Contemporary use of lipid-lowering therapy for secondary prevention in Korean patients with atherosclerotic cardiovascular diseases
  publication-title: Korean J Intern Med
  doi: 10.3904/kjim.2018.312
– volume: 47
  start-page: 101068
  year: 2022
  ident: pone.0304710.ref037
  article-title: Attainment of low-density lipoprotein cholesterol goals in statin treated patients: Real-world evidence from Australia.
  publication-title: Curr Probl Cardiol.
  doi: 10.1016/j.cpcardiol.2021.101068
– volume: 106
  start-page: 974
  year: 2002
  ident: pone.0304710.ref022
  article-title: Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000027560.41358.B3
– volume: 2
  start-page: 47
  year: 2017
  ident: pone.0304710.ref028
  article-title: Association between intensity of statin therapy and mortality in patients with atherosclerotic cardiovascular disease
  publication-title: JAMA Cardiol
  doi: 10.1001/jamacardio.2016.4052
– volume: 38
  start-page: e419
  year: 2023
  ident: pone.0304710.ref043
  article-title: Significant gap between guidelines and practice in the management of LDL cholesterol: insight from the survey of the Korean Society of Myocardial Infarction.
  publication-title: J Korean Med Sci
  doi: 10.3346/jkms.2023.38.e419
– volume: 34
  start-page: 1
  year: 2019
  ident: pone.0304710.ref014
  article-title: Current status of acute myocardial infarction in Korea.
  publication-title: Korean J Intern Med
  doi: 10.3904/kjim.2018.381
– volume: 8
  start-page: 789931
  year: 2021
  ident: pone.0304710.ref033
  article-title: Emerging non-statin treatment options for lowering low-density lipoprotein cholesterol.
  publication-title: Front Cardiovasc Med
  doi: 10.3389/fcvm.2021.789931
– volume: 75
  start-page: 2119
  year: 2020
  ident: pone.0304710.ref013
  article-title: Low-density lipoprotein cholesterol: lower is totally better
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2020.03.033
– volume: 8
  start-page: 204
  year: 2019
  ident: pone.0304710.ref031
  article-title: Should we intensify statin management in ACS patients with very low LDL cholesterol levels?
  publication-title: J Lipid Atheroscler
  doi: 10.12997/jla.2019.8.2.204
– volume: 23
  start-page: 206
  year: 2023
  ident: pone.0304710.ref003
  article-title: The global prevalence of myocardial infarction: a systematic review and meta-analysis
  publication-title: BMC Cardiovasc Disord
  doi: 10.1186/s12872-023-03231-w
SSID ssj0053866
Score 2.463163
Snippet Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean...
Background Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for...
BackgroundDyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for...
Background Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for...
SourceID plos
doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e0304710
SubjectTerms Aged
Biology and Life Sciences
Blood lipids
Cardiac patients
Cardiology
Cardiovascular disease
Care and treatment
Cholesterol
Cholesterol, LDL - blood
Clinical outcomes
Coronary vessels
Demographics
Drugs
Dyslipidemia
Dyslipidemias - drug therapy
Dyslipidemias - epidemiology
Evaluation
Ezetimibe - therapeutic use
Female
Heart attack
Heart attacks
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Ischemia
Lipids
Low density lipoprotein
Low density lipoproteins
Male
Management
Medical research
Medicine and Health Sciences
Medicine, Experimental
Metabolic disorders
Middle Aged
Mortality
Myocardial infarction
Myocardial Infarction - drug therapy
Myocardial Infarction - epidemiology
Patient monitoring
Patient outcomes
Population studies
Prescribing
Prescriptions
Prevalence
Republic of Korea - epidemiology
Review boards
Risk Factors
Risk reduction
Statins
Trends
Vein & artery diseases
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQnrggyquBthiEBBzSxrHzOhZEVUCABC3qBVl2bJeVtsmK7B7675mxvdEGVYID0p7icTY779mMvyHkhVIa6g7DUwWGlApbu7TmpU6VLQR8Cm38_x2fPpen5-LDRXGxNeoLe8ICPHBg3FHGdFs5ztBtilZwJXKdlbkrtMNZdN77Zk22KaaCDwYrLst4UI5X7CjK5XDZd_YQXwZWeGJ2KxB5vP7RK8-Wi364KeX8s3NyKxSd3CV3Yg5Jj8Oz75BbtrtHdqKVDvRVhJJ-fZ_8OLNdeg3KTFe-95XOO7qYL-eGXo1tL9TPG6IRYHWgfmo4vbqGIIfKs4A9DqwBBYjb_cw9-rGHZPMBOT95d_b2NI0DFdIWyoxVqp1QDTeiZqrNTdYYRG9nTdWAGB0XUCsppzPlrGEGwjjTeeaUY9q6umjbrOUPyawDFu4SmkH0M8JWrNECMQQVxEJTl0UllIGswSUk3XBXLgNuhvQvzyqoNwKbJEpDRmkk5A2KYKRF1Gt_AXRBRl2Qf9OFhDxFAcpwhHS0XXlcQ5JTipLD1zz3FIh80WFrzaVaD4N8_-X7PxB9-zohehmJXA-q0Kp4nAF-EyJqTSj3JpRgv-1keRfVbcOVQXJIgcFrQuYJOzcqePPys3EZb4rtcp3t14GmLqqqZAl5FDR25CwHViEIXkLqiS5PWD9d6eY_PfA41M6IJtQ8_h_CekJu55Ag-sZIvkdmq19ruw8J3kofeFv-DXDsTGw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELbK9sIFUV4NFDAICTikTWLndUCoRa0KiAWVFvVSWXZsl5W2ydLsHvrvmXGc0KAKIe1pPd7HPDwz8cw3hLySUkHeoVkowZBCbgobFixToTQph1eqtHve8WWaHZ7wT6fp6RqZ9r0wWFbZn4nuoNZNhc_IdxgEBqBL4I_fL36FODUKb1f7ERrSj1bQ7xzE2C2yDkdyGk3I-t7-9NtRfzaDdWeZb6Bjebzj5bW9aGqzjZeEOXbSXnNQDsd_OK0ni3nT3hSK_l1Rec1FHdwld3xsSXc7Zdgga6a-Rza89bb0jYeYfnufnB2bOrwCJadLVxNLZzWdzxYzTS-Gchjq5hBRD7zaUjdNnF5cgfNDpZrDHgtWgoLF7W4WH_3cQBD6gJwc7B9_OAz9oIWwgvRjGSrLZck0L2JZJToqNaK6x2Vegngt45BDSasiaY2ONbj3WCWRlTZWxhZpVUUVe0gmNbBwk9AIvKLmJo9LxRFbUIKP1EWW5lxqiCZsQMKeu2LR4WkId6mWQx7SsUmgNISXRkD2UAQDLaJhuzeay3PhjUtEsapyC7oBrpVXnEmeqChLbKoszitMAvIcBSi61tLBpsVuAcFPxjMGX_PSUSAiRo0lN-dy1bbi49cf_0H0_WhE9NoT2QZUoZK-zQH-EyJtjSi3RpRg19VoeRPVredKK_5YAOzsVfDm5RfDMn4oltHVpll1NEWa51kckEedxg6cZcAqBMcLSDHS5RHrxyv17KcDJIecGlGGysf__l1PyO0EQkJXCsm2yGR5uTJPIaRbqmfeTn8D4qlLgQ
  priority: 102
  providerName: ProQuest
Title Ten-year trends in lipid management among patients after myocardial infarction in South Korea
URI https://www.ncbi.nlm.nih.gov/pubmed/39361921
https://www.proquest.com/docview/3112793125
https://www.proquest.com/docview/3112857761
https://pubmed.ncbi.nlm.nih.gov/PMC11449489
https://doaj.org/article/01bc7f3129904c43a42b062f5bf93692
http://dx.doi.org/10.1371/journal.pone.0304710
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdG98ILYnytbBSDkICHVHHsfD0gtE0rA8RAY0V9QZEdx6NSl3RNK9H_njvHjQgq0qQoD_E5Ue4jdxeff0fIKykV5B2aexIMyRNFYryER8qTRSjgCJW2_zu-nEdnY_FpEk52yKZnq2NgvTW1w35S48Vs-Ptm_R4M_p3t2hCzzaThvCqLIS71xbjnateuGGExn2jXFcC67eolRi1eFPjcbab73106zspi-rdf7t58VtXbwtJ_qyv_clej--SeizPpUaMYe2SnKB-QPWfJNX3j4KbfPiQ_L4vSW4PC06Wtj6XTks6m86mm121pDLU9iagDYa2p7SxOr9fgCFHBZjDHgMWgkHG67ctHP1cQkD4i49Hp5cmZ55oueDmkIktPGSFTrkXCZB5oP9WI8M7SOAVRGy4gn5JG-dIUmmlw9UwFvpGGqcIkYZ77OX9MeiWwcJ9QHzykFkXMUiUQZ1CCPHQShbGQGiIL0yfehrvZvMHWyOwCWww5ScOmDKWROWn0yTGKoKVFZGx7oVpcZc7QMp-pPDacoZsVueBSBMqPAhMqg70Lgz55jgLMmm2mrX1nRwkEQpGIODzmpaVAdIwSy2-u5Kqus49ff9yC6PtFh-i1IzIVqEIu3ZYHeCdE3epQHnYowcbzzvA-qtuGK3XGIUyGLytEpzBzo4Lbh1-0w3hTLKkri2rV0CRhHEesT540GttylgOrECivT5KOLndY3x0pp78sODnk14g4lD69xYMPyN0AYkRbG8kPSW-5WBXPIMZbqgG5E09iOCcnDM-jDwOye3x6_u1iYP-aDKxZ_wEmFVPS
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdG9wAviPG1wGAGgYCHbPlwvh4mtMGmlm4FjQ7tBQU7jkelLilLK9R_jr-NO8cJC5oQL5P6VJ_T5ny-D_vud4S84FxA3CF9m8NGslkeKzv2Q2HzPGDwCYTU5x1Ho7B_wj6cBqcr5FdTC4NplY1O1IpalhmekW_74BiALIE9fjv7YWPXKLxdbVpocNNaQe5oiDFT2DHMlz8hhKt2Bu9hvV963sH--F3fNl0G7Ax877ktFOOJL1ns8syTTiIR0txNogTeTfkMAgiuhMNVLl0Jts0VnqO4ckWu4iDLnMyH594gqwwPUHpkdW9_9Om4sQWgTcLQFOz5kbtt5GNrVhb5Fl5KRli5e8kg6r4BrXXozaZldZXr-3cG5yWTeHCH3Da-LN2thW-NrOTFXbJmtEVFXxtI6zf3yNdxXthL4Bad6xxcOinodDKbSHrept9Q3feIGqDXiuru5fR8CcYWhXgKcxSwGwUJp-vef3RYgtN7n5xcC8sfkF4BLFwn1AErLFkeuYlgiGXIwSbLOAwixiV4L8oidsPddFbjd6T6Ei-CuKdmU4qrkZrVsMgeLkFLi-jb-ovy4iw1mzl1XJFFCmQRTDnLmM-ZJ5zQU4FQ2B_Rs8gmLmBal7K2OiTdjcHZClnow8881xSIwFFgis8ZX1RVOvj45T-IPh93iF4ZIlWCKGTclFXAOyGyV4dyo0MJeiTrDK-juDVcqdI_Ow5mNiJ49fCzdhgfiml7RV4uapo4iKLQtcjDWmJbzvrAKgTjs0jckeUO67sjxeS7BkCHGB5RjZJH__5fm-Rmf3x0mB4ORsPH5JYH7qhOw_Q3SG9-scifgDs5F0_NnqXk23Wrid9QsYpG
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGJyFeEOO2wGAGgYCHrLk4t4cJbWzVSqFMY0N7QcGO41GpS8rSCvUv8qs4x3HCgibEy6Q-1Sdpc_z5XOLj7xDygnMBeYf0bQ4LyWZ5rOzYD4XN84DBJxBSv-_4OA4PTtj70-B0hfxqzsJgWWVjE7WhlmWG78j7PgQGgCXwx31lyiIO9wZvZz9s7CCFO61NOw1u2izIbU03Zg55jPLlT0jnqu3hHsz9S88b7B-_O7BNxwE7gzh8bgvFeOJLFrs886STSKQ3d5MogedUPoNkgivhcJVLV4Kfc4XnKK5ckas4yDIn8-G-N8hqBF4fEsHV3f3x4VHjF8CyhKE5vOdHbt9gZWtWFvkWblBGeIr3knPUPQRaT9GbTcvqqjD472rOS-5xcIfcNnEt3amBuEZW8uIuWTOWo6KvDb31m3vk63Fe2EvQFp3relw6Keh0MptIet6W4lDdA4ka0teK6k7m9HwJjhcBPYVrFKgbQYWX6z6AdFRCAHyfnFyLyh-QXgEqXCfUAY8sWR65iWDIa8jBP8s4DCLGJUQyyiJ2o910VnN5pHpDL4IcqFZTirORmtmwyC5OQSuLTNz6i_LiLDULO3VckUUKcAlunWXM58wTTuipQCjslehZZBMnMK2Ptbb2JN2JIfAKWejDzzzXEsjGUSCuz_iiqtLhpy__IfT5qCP0ygipEqCQcXPEAp4JWb46khsdSbApWWd4HeHWaKVK_6w-uLKB4NXDz9phvCmW8BV5uahl4iCKQtciD2vEtpr1QVVIzGeRuIPljuq7I8XkuyZDh3weGY6SR__-X5vkJpiL9MNwPHpMbnkQmeqKTH-D9OYXi_wJRJZz8dQsWUq-XbeV-A311I6K
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ten-year+trends+in+lipid+management+among+patients+after+myocardial+infarction+in+South+Korea&rft.jtitle=PloS+one&rft.au=Oh%2C+Seok&rft.au=Cho%2C+Kyung+Hoon&rft.au=Kim%2C+Min+Chul&rft.au=Sim%2C+Doo+Sun&rft.date=2024-10-03&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=19&rft.issue=10&rft.spage=e0304710&rft_id=info:doi/10.1371%2Fjournal.pone.0304710&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon